Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MK-8931

- PMLiVE

MSD updates Univadis, adds apps

New UK version of its HCP website will allow users to personalise the portal

Merck & Co and GSK offer discounted cervical vaccines to developing nations

Pharma companies team up with GAVI Alliance to provide Cervarix and Gardasil

- PMLiVE

Baxter’s Gammagard latest disappointment in Alzheimer’s

Fails to show improvement in cognitive and functional measures

- PMLiVE

Merck cuts outlook as Q1 sales fall

But new R&D chief highlights potential of company's near-term pipeline

- PMLiVE

Otsuka licenses Lundbeck’s Alzheimer’s drug in $825m deal

Lu AE58054 is in phase III development as add-on to donepezil

- PMLiVE

FDA explains draft Alzheimer’s guidance in NEJM editorial

Intends to relax requirements in patient function and cognition

- PMLiVE

Merck taps Luminex for Alzheimer’s biomarker

Licenses companion diagnostic to use in its clinical trials

- PMLiVE

Merck forges on with Vytorin trial after safety review

Won't halt controversial study of its cholesterol drug

Digital reach is ‘gold dust’ for pharma

How companies perform online will be a key differentiating factor, says Merck & Co's Gerhard Arnhofer

- PMLiVE

FDA proffers guidance for new Alzheimer’s drugs

Encourages approach that tackles disease in its early stages

- PMLiVE

Merck resubmits anaesthesia drug Bridion in US

FDA previous the neuromuscular reversal agent in 2008

Canadian charity aims to tackle stigma of dementia

Alzheimer Society launches campaign during its Alzheimer’s Awareness Month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links